XGN
Analyst Coverage

No analyst coverage available for this stock.

PRICE
Prev Close
4.27
Open
4.30
Day Range4.11 – 4.33
4.11
4.33
52W Range2.59 – 12.23
2.59
12.23
17% of range
VOLUME & SIZE
Avg Volume
379.5K
FUNDAMENTALS
P/E Ratio
-4.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.09
Market-like
TECHNICAL
RSI (14)
55
Bullish momentum

XGN News

About

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Fortunato Rocca